MILLIPLEX® MAP EpiQuant™ A431 Cell Lysate: EGF

Product Image
MILLIPLEX® MAP EpiQuant™ A431 Cell Lysate: EGF
  • placeholder

MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of EpiQuant-bearing peptides.

Receive your quote directly from EMD Millipore, a division of Merck KGaA, Darmstadt, Germany for MILLIPLEX® MAP EpiQuant™ A431 Cell Lysate: EGF

Description

MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of EpiQuant-bearing peptides.

Product Overview

Product Image

MILLIPLEX® MAP EpiQuant™ A431 Cell Lysate: EGF

by EMD Millipore, a division of Merck KGaA, Darmstadt, Germany







Receive your quote directly from EMD Millipore, a division of Merck KGaA, Darmstadt, Germany for MILLIPLEX® MAP EpiQuant™ A431 Cell Lysate: EGF